Fiche publication


Date publication

juin 2018

Journal

Biochimica et biophysica acta

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DUCA Laurent


Tous les auteurs :
Vallin B, Legueux-Cajgfinger Y, Clément N, Glorian M, Duca L, Vincent P, Limon I, Blaise R

Résumé

Here, we cloned a new family of four adenylyl cyclase (AC) splice variants from interleukin-1β (IL-1β)-transdifferentiated vascular smooth muscle cells (VSMCs) encoding short forms of AC8 that we have named "AC8E-H". Using biosensor imaging and biochemical approaches, we showed that AC8E-H isoforms have no cyclase activity and act as dominant-negative regulators by forming heterodimers with other full-length ACs, impeding the traffic of functional units towards the plasma membrane. The existence of these dominant-negative isoforms may account for an additional unsuspected degree of cAMP signaling regulation. It also reconciles the induction of an AC in transdifferentiated VSMCs with the vasoprotective influence of cAMP. The generation of alternative splice variants of ACs may constitute a generalized strategy of adaptation to the cell's environment whose scope had so far been ignored in physiological and/or pathological contexts.

Mots clés

Dominant-negative, Heterodimerization, Short adenylyl cyclases, Vascular smooth muscle cells, cAMP signaling

Référence

Biochim. Biophys. Acta. 2018 Jun 22;: